Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this non-interventional, retrospective study of existing data is to evaluate clinical outcomes related to Methicillin-resistant Staphylococcus aureus hospital based pneumonia by treatment and among subpopulations.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Linezolid; Methicillin; Vancomycin

Criteria

Inclusion Criteria:

• MRSA and pneumonia cases by ICD-9 code identification.

• Diagnosis included during inpatient stay.

• Treatment initiation in hospital.

Exclusion Criteria:

• Death of discharge within 3 days of treatment initiation.

• Exposure to other treatments with MRSA activity.